Cargando…
Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803998/ https://www.ncbi.nlm.nih.gov/pubmed/35102145 http://dx.doi.org/10.1038/s41408-022-00618-4 |
| _version_ | 1784642992028516352 |
|---|---|
| author | Fiskus, Warren Manshouri, Taghi Birdwell, Christine Mill, Christopher P. Masarova, Lucia Bose, Prithviraj Kadia, Tapan M. Daver, Naval DiNardo, Courtney D. Borthakur, Gautam Khoury, Joseph D. Verstovsek, Srdan Bhalla, Kapil N. |
| author_facet | Fiskus, Warren Manshouri, Taghi Birdwell, Christine Mill, Christopher P. Masarova, Lucia Bose, Prithviraj Kadia, Tapan M. Daver, Naval DiNardo, Courtney D. Borthakur, Gautam Khoury, Joseph D. Verstovsek, Srdan Bhalla, Kapil N. |
| author_sort | Fiskus, Warren |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8803998 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88039982022-02-07 Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells Fiskus, Warren Manshouri, Taghi Birdwell, Christine Mill, Christopher P. Masarova, Lucia Bose, Prithviraj Kadia, Tapan M. Daver, Naval DiNardo, Courtney D. Borthakur, Gautam Khoury, Joseph D. Verstovsek, Srdan Bhalla, Kapil N. Blood Cancer J Correspondence Nature Publishing Group UK 2022-01-31 /pmc/articles/PMC8803998/ /pubmed/35102145 http://dx.doi.org/10.1038/s41408-022-00618-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correspondence Fiskus, Warren Manshouri, Taghi Birdwell, Christine Mill, Christopher P. Masarova, Lucia Bose, Prithviraj Kadia, Tapan M. Daver, Naval DiNardo, Courtney D. Borthakur, Gautam Khoury, Joseph D. Verstovsek, Srdan Bhalla, Kapil N. Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells |
| title | Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells |
| title_full | Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells |
| title_fullStr | Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells |
| title_full_unstemmed | Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells |
| title_short | Efficacy of CDK9 inhibition in therapy of post-myeloproliferative neoplasm (MPN) secondary (s) AML cells |
| title_sort | efficacy of cdk9 inhibition in therapy of post-myeloproliferative neoplasm (mpn) secondary (s) aml cells |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803998/ https://www.ncbi.nlm.nih.gov/pubmed/35102145 http://dx.doi.org/10.1038/s41408-022-00618-4 |
| work_keys_str_mv | AT fiskuswarren efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells AT manshouritaghi efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells AT birdwellchristine efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells AT millchristopherp efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells AT masarovalucia efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells AT boseprithviraj efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells AT kadiatapanm efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells AT davernaval efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells AT dinardocourtneyd efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells AT borthakurgautam efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells AT khouryjosephd efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells AT verstovseksrdan efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells AT bhallakapiln efficacyofcdk9inhibitionintherapyofpostmyeloproliferativeneoplasmmpnsecondarysamlcells |